PL1761510T3 - Sposób wytwarzania 4-(benzimidazolilometyloamino)-benzamidyn - Google Patents

Sposób wytwarzania 4-(benzimidazolilometyloamino)-benzamidyn

Info

Publication number
PL1761510T3
PL1761510T3 PL05769631T PL05769631T PL1761510T3 PL 1761510 T3 PL1761510 T3 PL 1761510T3 PL 05769631 T PL05769631 T PL 05769631T PL 05769631 T PL05769631 T PL 05769631T PL 1761510 T3 PL1761510 T3 PL 1761510T3
Authority
PL
Poland
Prior art keywords
benzimidazolylmethylamino
benzamidines
producing
Prior art date
Application number
PL05769631T
Other languages
English (en)
Polish (pl)
Inventor
Georg Zerban
Arndt Hausherr
Kerstin Schlarb
Heinz-Peter Schmitt
Björn Weyell
Gunter Koch
Rainer Hamm
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34925482&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1761510(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of PL1761510T3 publication Critical patent/PL1761510T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C07D271/07—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
PL05769631T 2004-06-25 2005-06-18 Sposób wytwarzania 4-(benzimidazolilometyloamino)-benzamidyn PL1761510T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04014917A EP1609784A1 (de) 2004-06-25 2004-06-25 Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen
PCT/EP2005/006586 WO2006000353A1 (de) 2004-06-25 2005-06-18 Verfahren zur herstellung von 4-(benzimidazolylmethylamino)- benzamidinen
EP05769631.2A EP1761510B1 (de) 2004-06-25 2005-06-18 Verfahren zur herstellung von 4-(benzimidazolylmethylamino)- benzamidinen

Publications (1)

Publication Number Publication Date
PL1761510T3 true PL1761510T3 (pl) 2015-10-30

Family

ID=34925482

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05769631T PL1761510T3 (pl) 2004-06-25 2005-06-18 Sposób wytwarzania 4-(benzimidazolilometyloamino)-benzamidyn

Country Status (20)

Country Link
US (2) US7202368B2 (enExample)
EP (2) EP1609784A1 (enExample)
JP (1) JP5073486B2 (enExample)
KR (1) KR101298507B1 (enExample)
CN (1) CN1972919B (enExample)
AR (1) AR049410A1 (enExample)
AU (1) AU2005256424B2 (enExample)
BR (1) BRPI0511318B8 (enExample)
CA (1) CA2570499C (enExample)
DK (1) DK1761510T3 (enExample)
ES (1) ES2543982T3 (enExample)
HU (1) HUE027198T2 (enExample)
IL (2) IL180247A (enExample)
MX (1) MXPA06015210A (enExample)
NZ (1) NZ552809A (enExample)
PL (1) PL1761510T3 (enExample)
RU (1) RU2401264C2 (enExample)
TW (1) TWI364417B (enExample)
WO (1) WO2006000353A1 (enExample)
ZA (1) ZA200609918B (enExample)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030181488A1 (en) 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
DE10339862A1 (de) * 2003-08-29 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)- phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester-Methansulfonat und dessen Verwendung als Arzneimittel
DE102005020002A1 (de) * 2005-04-27 2006-11-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Physiologisch verträgliche Salze von 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester
DE102005061624A1 (de) 2005-12-21 2007-06-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verbessertes Verfahren zur Herstellung von Salzen von 4-(Benzimidazolylmethylamino)-Benzamidinen
DE102005061623A1 (de) * 2005-12-21 2007-06-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verbessertes Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen und deren Salzen
US20100087488A1 (en) * 2006-10-10 2010-04-08 Boehringer Ingelheim International Gmgh Physiologically Acceptable Salts of 3-[(2--1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester
DE102006054005A1 (de) * 2006-11-16 2008-05-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Polymorphe von 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester
EP1956018A1 (de) * 2007-02-06 2008-08-13 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung eines Benzimidazolderivats
CZ305085B6 (cs) 2008-03-14 2015-04-29 Zentiva, K.S. Způsob přípravy dabigatranu
US20110129538A1 (en) * 2008-03-28 2011-06-02 Boehringer Ingelheim International Gmbh Process for preparing orally administered dabigatran formulations
NZ588488A (en) * 2008-06-16 2012-08-31 Boehringer Ingelheim Int Method for producing an intermediate product of dabigatran etexilate
TWI436994B (zh) 2008-07-14 2014-05-11 Boehringer Ingelheim Int 製備含有達比加群（ｄａｂｉｇａｔｒａｎ）之藥物組合物的新穎方法
CZ2008669A3 (cs) * 2008-10-24 2010-05-05 Zentiva, A. S. Zpusob prípravy dabigatranu a jeho meziprodukty
CN102050815B (zh) * 2009-11-06 2014-04-02 北京美倍他药物研究有限公司 作为前药的达比加群的酯衍生物
CN102050814B (zh) * 2009-11-06 2014-05-28 北京美倍他药物研究有限公司 达比加群的酯衍生物
US8399678B2 (en) * 2009-11-18 2013-03-19 Boehringer Ingelheim International Gmbh Process for the manufacture of dabigatran etexilate
WO2012004397A1 (en) 2010-07-09 2012-01-12 Esteve Química, S.A. Intermediates and process for preparing a thrombin specific inhibitor
MX2013000295A (es) 2010-07-09 2013-05-28 Esteve Quimica Sa Procedimiento de preparacion de un inhibidor especifico de la trombina.
HUE026408T2 (en) 2010-09-27 2016-06-28 Ratiopharm Gmbh Dabigatran etexylate bis-mesylate salt, solid forms and process for their preparation
WO2012077136A2 (en) * 2010-12-06 2012-06-14 Msn Laboratories Limited Process for the preparation of benzimidazole derivatives and its salts
EP2522662A1 (en) 2011-05-11 2012-11-14 Medichem, S.A. Dabigatran etexilate and related substances, processes and compositions, and use of the substances as reference standards and markers
HUP1100244A2 (hu) 2011-05-11 2012-11-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Gyógyszeripari intermedierek és eljárás elõállításukra
WO2013111163A2 (en) 2012-01-20 2013-08-01 Cadila Healthcare Limited Process for the preparation of dabigatran etexilate mesylate and polymorphs of intermediates thereof
EP2834224B1 (en) 2012-04-02 2018-06-06 MSN Laboratories Limited Process for the preparation of benzimidazole derivatives and salts thereof
WO2014020555A2 (en) * 2012-08-01 2014-02-06 Alembic Pharmaceuticals Limited An improved process for the preparation of dabigatran etexilate mesylate
US20150246899A1 (en) * 2012-09-28 2015-09-03 Ranbaxy Laboratories Limited Process for the preparation of dabigatran etexilate or pharmaceutically acceptable salt thereof
US9399616B2 (en) 2012-10-22 2016-07-26 Boehringer Ingelheim International Gmbh Process for the manufacture of 4-aminobenzoamidine dihydrochloride
US10077251B2 (en) 2012-10-29 2018-09-18 Biophore India Pharmaceuticals Pvt. Ltd. Process for the synthesis of Dabigatran Etexilate and its intermediates
US9533971B2 (en) 2012-10-29 2017-01-03 Biophore India Pharmaceuticals Pvt. Ltd Process for the synthesis of dabigatran and its intermediates
WO2014178017A1 (en) * 2013-04-30 2014-11-06 Ranbaxy Laboratories Limited Dabigatran etexilate impurity, process of its preparation, and its use as a reference standard
EP2835370A1 (en) 2013-08-08 2015-02-11 Medichem, S.A. New crystals of dabigatran etexilate mesylate
CN103626740B (zh) * 2013-12-05 2015-02-04 南京欧信医药技术有限公司 一种化合物的合成方法
CN103772358A (zh) * 2014-01-07 2014-05-07 万特制药(海南)有限公司 一种制备达比加群酯的合成方法
WO2015128875A2 (en) 2014-02-26 2015-09-03 Megafine Pharma (P) Ltd. A process for preparation of dabigatran etexilate mesylate and intermediates thereof
CN105461686A (zh) * 2014-08-25 2016-04-06 江苏豪森药业股份有限公司 制备高纯度甲磺酸达比加群酯晶型的方法
CN104910047B (zh) * 2015-05-11 2017-06-06 常州市阳光药业有限公司 达比加群酯中间体的制备方法
EP3848998A4 (en) 2018-10-29 2021-11-24 LG Chem, Ltd. SEPARATOR FOR ELECTROCHEMICAL DEVICE AND METHOD FOR MANUFACTURING IT
EP3771465A1 (en) 2019-08-01 2021-02-03 Zaklady Farmaceutyczne Polpharma SA Pharmaceutical composition comprising dabigatran etexilate
CN116178252A (zh) * 2022-07-26 2023-05-30 浙江海翔药业股份有限公司 一种甲磺酸达比加群酯的原料杂质及其制备方法和用途
CN116354952A (zh) * 2023-01-06 2023-06-30 宿迁盛基医药科技有限公司 一种达比加群酯关键中间体的合成工艺

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19516483A1 (de) * 1995-05-05 1996-11-07 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
PE121699A1 (es) * 1997-02-18 1999-12-08 Boehringer Ingelheim Pharma Heterociclos biciclicos disustituidos como inhibidores de la trombina
US6414008B1 (en) * 1997-04-29 2002-07-02 Boehringer Ingelheim Pharma Kg Disubstituted bicyclic heterocycles, the preparation thereof, and their use as pharmaceutical compositions
TWI248435B (en) * 1998-07-04 2006-02-01 Boehringer Ingelheim Pharma Benzimidazoles, the preparation thereof and their use as pharmaceutical compositions
US6248770B1 (en) * 1998-07-09 2001-06-19 Boehringer Ingelheim Pharma Kg Benzimidazoles having antithrombotic activity
DE19924818A1 (de) * 1999-05-29 2000-11-30 Bayer Ag Substituierte Phenylcyclohexancarbonsäureamide
US6451832B2 (en) * 1999-12-23 2002-09-17 Boehringer Ingelheim Pharma Kg Benzimidazoles with antithrombotic activity
DE19962329A1 (de) * 1999-12-23 2001-06-28 Boehringer Ingelheim Pharma Benzimidazole, deren Herstellung und deren Verwendung als Arzneimittel
EP1574516A1 (en) * 2004-03-05 2005-09-14 Sanofi-Aventis Antithrombotic compound

Also Published As

Publication number Publication date
TW200613287A (en) 2006-05-01
US20070149589A1 (en) 2007-06-28
RU2401264C2 (ru) 2010-10-10
JP2008503519A (ja) 2008-02-07
NZ552809A (en) 2009-06-26
HUE027198T2 (en) 2016-08-29
CN1972919A (zh) 2007-05-30
BRPI0511318A (pt) 2007-12-04
US7459566B2 (en) 2008-12-02
KR101298507B1 (ko) 2013-08-22
EP1609784A1 (de) 2005-12-28
EP1761510A1 (de) 2007-03-14
US20060004064A1 (en) 2006-01-05
EP1761510B1 (de) 2015-05-13
CN1972919B (zh) 2012-06-27
RU2007102631A (ru) 2008-07-27
IL180247A0 (en) 2007-07-04
AU2005256424A1 (en) 2006-01-05
MXPA06015210A (es) 2007-03-15
BRPI0511318B8 (pt) 2021-05-25
IL180247A (en) 2011-11-30
AU2005256424B2 (en) 2011-12-08
IL211491A0 (en) 2011-05-31
BRPI0511318B1 (pt) 2018-02-14
AR049410A1 (es) 2006-07-26
KR20070029817A (ko) 2007-03-14
JP5073486B2 (ja) 2012-11-14
US7202368B2 (en) 2007-04-10
ZA200609918B (en) 2008-10-29
WO2006000353A1 (de) 2006-01-05
DK1761510T3 (en) 2015-08-17
CA2570499C (en) 2013-08-06
IL211491A (en) 2012-05-31
TWI364417B (en) 2012-05-21
CA2570499A1 (en) 2006-01-05
ES2543982T3 (es) 2015-08-26

Similar Documents

Publication Publication Date Title
PL1761510T3 (pl) Sposób wytwarzania 4-(benzimidazolilometyloamino)-benzamidyn
IL183091A0 (en) Method for preparing n-phenylpyrazole-1-carboxyamides
IL176767A0 (en) Production method
IL185627A0 (en) Alkyl-anilide producing method
EP1767538A4 (en) PROCESS FOR PREPARING A 1-OXACEPHALOSPORIN-7ALPHA-METHOXY-3-CHLOROMETHYL DERIVATIVE
IL177233A0 (en) Method for producing polyisobutenylphenols
PL1831223T3 (pl) Sposób wytwarzania L-biopteryny
PL382927A1 (pl) Sposoby wytwarzania 4-aminochinazolin
EP1785397A4 (en) PROCESS FOR THE PREPARATION OF CARBONATE
EP1767563A4 (en) PROCESS FOR PREPARING POLYETHERES
EP1835049A4 (en) PROCESS FOR PRODUCING METAL
GB0410103D0 (en) New method
EP1780192A4 (en) PROCESS FOR PREPARING A DIBROMFLUORBENZOLE DERIVATIVE
IL178087A0 (en) Method for producing semicarbazones
IL181075A0 (en) Process for producing 2-(4-methyl-2-phenylpiperazine-1-yl)-3-cyanopiridine
ZA200700599B (en) Method for producing (Z)-1-phenyl-1-diethylamino-carbonyl-2-hydroxymethyl cyclopropane
GB0723334D0 (en) Method for producing substituted halopyridines
EP1836310A4 (en) PROCESS FOR PREPARING PROBIOTICALLY OBTAINED COMPOUNDS
ZA200708847B (en) Method for producing sulfamate-carboxylate derivative
TWI315261B (en) Method for transferring-printing
ZA200709013B (en) Method for producing 2-isopropenyl-5-methyl-4-hexen-1-yl 3-methyl-2-butenoate
GB2413325B (en) Process for producing 2-benzoyloxyacetaldehyde derivative
HU0400351D0 (en) Method for producing dialkyl-3-oxo-glutarates
EP1903047A4 (en) PROCESS FOR THE PREPARATION OF TRIHYDROCARBYLBORAN
PL366494A1 (en) Method for obtaining 5-nitroguaiacol